Membranous glomerulonephritis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* The membranous Glomerulonephritis is a rare disease. | * The membranous Glomerulonephritis is a rare disease.<ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="pmid27365535" /> | *The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="pmid27365535" /> | ||
| Line 13: | Line 13: | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="pmid27365535" /><ref name="pmid24715030" /> | *The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="pmid27365535" /><ref name="pmid24715030" /><ref name="pmid10620560">{{cite journal |vauthors=Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P |title=Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study |journal=Am. J. Kidney Dis. |volume=35 |issue=1 |pages=157–65 |date=January 2000 |pmid=10620560 |doi=10.1016/S0272-6386(00)70316-7 |url=}}</ref> | ||
*In 2002, the prevalence of [disease name] was estimated to be 690 cases per 100,000 individuals worldwide. | *In 2002, the prevalence of [disease name] was estimated to be 690 cases per 100,000 individuals worldwide. | ||
===Mortality rate=== | ===Mortality rate=== | ||
*In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a mortality rate of 0.38%.<ref name="pmid27365535" /><ref name="pmid24715030" /> | *In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a mortality rate of 0.38%.<ref name="pmid27365535" /><ref name="pmid24715030" /><ref name="pmid10620560">{{cite journal |vauthors=Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P |title=Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study |journal=Am. J. Kidney Dis. |volume=35 |issue=1 |pages=157–65 |date=January 2000 |pmid=10620560 |doi=10.1016/S0272-6386(00)70316-7 |url=}}</ref> | ||
*The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38% | *The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38% | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop membranous glomerulonephritis. | *Patients of all age groups may develop membranous glomerulonephritis.<ref name="pmid10620560">{{cite journal |vauthors=Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P |title=Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study |journal=Am. J. Kidney Dis. |volume=35 |issue=1 |pages=157–65 |date=January 2000 |pmid=10620560 |doi=10.1016/S0272-6386(00)70316-7 |url=}}</ref> | ||
*The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years. | *The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years. | ||
*Membranous Glomerulonephritis commonly affects individuals older than 40 years of age. | *Membranous Glomerulonephritis commonly affects individuals older than 40 years of age. | ||
| Line 27: | Line 27: | ||
===Race=== | ===Race=== | ||
*membranous glomerulopathy usually affects individuals of the caucasian race and Chinese population. | *membranous glomerulopathy usually affects individuals of the caucasian race and Chinese population.<ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> <ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
* Membranous glomerulonephritis affects men and women equally. | * Membranous glomerulonephritis affects men and women equally.<ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> <ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref> | ||
===Region=== | ===Region=== | ||
* Membranous glomerulonephritis tends to affect Caucasian population and Chinese population. | * Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> <ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref> | ||
===Developed Countries=== | ===Developed Countries=== | ||
Revision as of 22:56, 18 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics |
|
FDA on Membranous glomerulonephritis epidemiology and demographics |
|
CDC on Membranous glomerulonephritis epidemiology and demographics |
|
Membranous glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranous glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000.
Epidemiology and Demographics
- The membranous Glomerulonephritis is a rare disease.[1]
Incidence
- The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.[2]
- In 2002, the incidence of membranous glomerulopathy was estimated to be 27 cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.[2][3][4]
- In 2002, the prevalence of [disease name] was estimated to be 690 cases per 100,000 individuals worldwide.
Mortality rate
- In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a mortality rate of 0.38%.[2][3][4]
- The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38%
Age
- Patients of all age groups may develop membranous glomerulonephritis.[4]
- The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years.
- Membranous Glomerulonephritis commonly affects individuals older than 40 years of age.
Race
- membranous glomerulopathy usually affects individuals of the caucasian race and Chinese population.[2] [3]
Gender
Region
Developed Countries
Developing Countries
References
- ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
- ↑ 3.0 3.1 3.2 3.3 3.4 Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
- ↑ 4.0 4.1 4.2 Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (January 2000). "Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study". Am. J. Kidney Dis. 35 (1): 157–65. doi:10.1016/S0272-6386(00)70316-7. PMID 10620560.